Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-04-13

Clinical Trial Update: Effect of Antimalarial Drugs to Rabies Vaccine for Post-exposure Prophylaxis. [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating the effect of antimalarial drugs on rabies vaccine for post-exposure prophylaxis has completed, with results posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: State University of New York - Upstate Medical University | Conditions: Rabies | Phase 4 | Status: COMPLETED | Results posted: 2021-04-13